DE60043959D1 - Ophthalmischer Einsatz und Verfahren zur stetigen Zuführung eines Arzneimittels ins Auge - Google Patents

Ophthalmischer Einsatz und Verfahren zur stetigen Zuführung eines Arzneimittels ins Auge

Info

Publication number
DE60043959D1
DE60043959D1 DE60043959T DE60043959T DE60043959D1 DE 60043959 D1 DE60043959 D1 DE 60043959D1 DE 60043959 T DE60043959 T DE 60043959T DE 60043959 T DE60043959 T DE 60043959T DE 60043959 D1 DE60043959 D1 DE 60043959D1
Authority
DE
Germany
Prior art keywords
eye
pore
insert
body portion
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60043959T
Other languages
English (en)
Inventor
Bruce E Cohan
Howard Diamond
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EYELAB GROUP LLC
Original Assignee
EYELAB GROUP LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23134640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60043959(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by EYELAB GROUP LLC filed Critical EYELAB GROUP LLC
Application granted granted Critical
Publication of DE60043959D1 publication Critical patent/DE60043959D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
DE60043959T 1999-04-19 2000-04-07 Ophthalmischer Einsatz und Verfahren zur stetigen Zuführung eines Arzneimittels ins Auge Expired - Lifetime DE60043959D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/294,720 US6196993B1 (en) 1998-04-20 1999-04-19 Ophthalmic insert and method for sustained release of medication to the eye

Publications (1)

Publication Number Publication Date
DE60043959D1 true DE60043959D1 (de) 2010-04-15

Family

ID=23134640

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60043959T Expired - Lifetime DE60043959D1 (de) 1999-04-19 2000-04-07 Ophthalmischer Einsatz und Verfahren zur stetigen Zuführung eines Arzneimittels ins Auge
DE60035979T Expired - Lifetime DE60035979T2 (de) 1999-04-19 2000-04-07 Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60035979T Expired - Lifetime DE60035979T2 (de) 1999-04-19 2000-04-07 Augeneinlage und verfahren zur verzögerten freisetzung einer arznei ins auge

Country Status (9)

Country Link
US (1) US6196993B1 (de)
EP (2) EP1891942B1 (de)
AT (2) ATE369843T1 (de)
AU (1) AU4205900A (de)
DE (2) DE60043959D1 (de)
DK (2) DK1178779T3 (de)
ES (2) ES2288471T3 (de)
PT (2) PT1891942E (de)
WO (1) WO2000062760A1 (de)

Families Citing this family (128)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20050119737A1 (en) * 2000-01-12 2005-06-02 Bene Eric A. Ocular implant and methods for making and using same
US20040208910A1 (en) * 2000-04-26 2004-10-21 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of adrenergic agents
US20040175410A1 (en) * 2000-04-26 2004-09-09 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
DE60114229T2 (de) 2000-11-29 2006-07-06 Allergan, Inc., Irvine Verhinderung von transplantatabstossung im auge
WO2002100318A2 (en) 2001-06-12 2002-12-19 Johns Hopkins University School Of Medicine Reservoir device for intraocular drug delivery
US7556621B2 (en) * 2001-06-29 2009-07-07 The Board Of Trustees Of The Leland Stanford Junior University Optically controlled microfluidic chip
EP1283025A1 (de) * 2001-08-10 2003-02-12 Stöckert Instrumente GmbH Ballonokklusionsvorrichtung
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
FR2834446B1 (fr) * 2002-01-08 2004-02-13 Ioltechnologie Production Clou meatique a expansion
CA2473355C (en) 2002-01-18 2012-01-03 Michael E. Snyder Sustained release ophthalmological device and method of making and using the same
PL205443B1 (pl) 2002-03-11 2010-04-30 Alcon Wszczepiane urządzenie do podawania leku, zwłaszcza do oka
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
JP2006516619A (ja) * 2003-01-24 2006-07-06 コントロール・デリバリー・システムズ・インコーポレイテッド 炭酸脱水酵素阻害剤を眼へ輸送するために徐放性デバイス及び方法
WO2004066979A2 (en) * 2003-01-24 2004-08-12 Control Delivery Systems, Inc. Sustained release device and method for ocular delivery of adrenergic agents
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
WO2005023181A2 (en) * 2003-08-22 2005-03-17 Vista Scientific Polymeric systems for controlled drug therapy
US20050197614A1 (en) * 2004-03-04 2005-09-08 Wilson Pritchard Occlusive biomedical devices, punctum plugs, and methods of use thereof
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
EP3470108A1 (de) * 2004-07-02 2019-04-17 Mati Therapeutics Inc. Vorrichtung zur abgabe eines behandlungsmittels im auge
US20060020253A1 (en) * 2004-07-26 2006-01-26 Prescott Anthony D Implantable device having reservoir with controlled release of medication and method of manufacturing the same
WO2006014793A1 (en) * 2004-07-26 2006-02-09 Clarity Corporation Implantable device having reservoir with controlled release of medication and method of manufacturing the same
US7117870B2 (en) 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods
WO2006039459A1 (en) * 2004-09-30 2006-04-13 Bausch & Lomb Incorporated Capsule for encasing tablets for surgical insertion into the human body
WO2006068898A1 (en) * 2004-12-22 2006-06-29 Bausch & Lomb Incorporated Reusable drug delivery device
EP2182078B1 (de) * 2005-09-01 2012-02-01 Bristol-Myers Squibb Company Biomarker und Verfahren zur Bestimmung der Empfindlichkeit gegen VEGFR2 modulator.
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
US7862532B2 (en) * 2005-10-07 2011-01-04 Delta Life Sciences, Inc. Punctum plugs having insertion guides and strengthening beams
KR20090006153A (ko) 2006-03-31 2009-01-14 큐엘티 플러그 딜리버리, 인코포레이티드 비루관계에 대한 약물 전달 방법, 구조, 및 조성물
US7981096B2 (en) * 2006-05-12 2011-07-19 David Castillejos Optic nerve head implant and medication delivery system
US9173773B2 (en) * 2006-06-21 2015-11-03 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
CN101505694B (zh) * 2006-06-21 2012-02-22 庄臣及庄臣视力保护公司 用于递送活性试剂的泪点塞
SG138567A1 (en) * 2006-06-21 2008-01-28 Johnson & Johnson Vision Care Punctal plugs for the delivery of active agents
US9474645B2 (en) * 2006-06-21 2016-10-25 Johnson & Johnson Vision Care, Inc. Punctal plugs for the delivery of active agents
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
WO2008024435A2 (en) * 2006-08-23 2008-02-28 Vanderbilt University Dendritic molecular intracellular transporters and methods of making and using same
US20080086101A1 (en) * 2006-08-25 2008-04-10 David Freilich Ophthalmic insert
KR20090102810A (ko) * 2006-12-26 2009-09-30 큐엘티 플러그 딜리버리, 인코포레이티드 시력 결함을 억제하기 위한 약물 전달 임플란트
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
MX2010002616A (es) * 2007-09-07 2010-08-04 Qlt Plug Delivery Inc Nucleos de farmaco para la liberacion sostenida de agentes terapeuticos.
WO2009035567A2 (en) * 2007-09-07 2009-03-19 Qlt Plug Delivery, Inc Insertion and extraction tools for lacrimal implants
NZ583861A (en) 2007-09-07 2012-08-31 Quadra Logic Tech Inc Lacrimal implants with an angled intersection between its sections so as to bias a portion of the body against the tissue surface
NZ583858A (en) * 2007-09-07 2012-08-31 Quadra Logic Tech Inc Lacrimal implant detection with detection device
US11254786B2 (en) 2007-11-05 2022-02-22 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
US20110274620A1 (en) * 2007-11-05 2011-11-10 Harth Eva M Multifunctional degradable nanoparticles with control over size and functionalities
ES2744834T3 (es) 2007-11-05 2020-02-26 Univ Vanderbilt Nanopartículas degradables multifuncionales con control sobre el tamaño y las funcionalidades
US20130142733A1 (en) 2007-11-05 2013-06-06 Vanderbilt University Multifunctional degradable nanoparticles with control over size and functionalities
WO2009079559A1 (en) * 2007-12-17 2009-06-25 University Of Florida Research Foundation, Inc. Dry eye treatment by puncta plugs
WO2009097468A2 (en) 2008-01-29 2009-08-06 Kliman Gilbert H Drug delivery devices, kits and methods therefor
WO2009105178A2 (en) * 2008-02-18 2009-08-27 Qlt Plug Delivery, Inc. Lacrimal implants and related methods
WO2009134371A2 (en) 2008-04-30 2009-11-05 Qlt Plug Delivery, Inc. Composite lacrimal insert and related methods
TWI542338B (zh) * 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
US9949942B2 (en) * 2008-05-09 2018-04-24 Mati Therapeutics Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US8894602B2 (en) 2010-09-17 2014-11-25 Johnson & Johnson Vision Care, Inc. Punctal plugs with directional release
US20090318549A1 (en) * 2008-06-24 2009-12-24 Qlt Plug Delivery, Inc. Combination treatment of glaucoma
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
CA2747556A1 (en) * 2008-12-19 2010-06-24 Qlt Inc. Substance delivering punctum implants and methods
CN102341144B (zh) * 2009-01-23 2014-10-29 Qlt股份有限公司 一种或多种药剂的持续释放递送
SG173167A1 (en) 2009-01-29 2011-08-29 Forsight Labs Llc Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
EP2396070A4 (de) 2009-02-12 2012-09-19 Incept Llc Wirkstofffreisetzung mit hydrogel-plugs
WO2010096822A2 (en) * 2009-02-23 2010-08-26 Qlt Plug Delivery, Inc. Lacrimal implants and related methods
WO2010101758A1 (en) 2009-03-03 2010-09-10 Alcon Research, Ltd. Peri-corneal drug delivery device
WO2010105130A2 (en) * 2009-03-13 2010-09-16 Vista Scientific Llc Opthalmic drug delivery system and applications
TW201043211A (en) * 2009-03-31 2010-12-16 Johnson & Johnson Vision Care Inc Punctal plugs
TWI495459B (zh) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care 淚管塞（二）
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8808257B2 (en) * 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
WO2011094170A1 (en) 2010-01-27 2011-08-04 Alcon Research, Ltd. Pulsatile peri-corneal drug delivery device
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259352B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
JP2013526572A (ja) 2010-05-17 2013-06-24 アエリエ・ファーマシューティカルズ・インコーポレーテッド 眼治療薬の送達のための薬物送達装置
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
HUE054113T2 (hu) 2010-08-05 2021-08-30 Forsight Vision4 Inc Injekciós készülék gyógyszerbejuttatáshoz
CA2807537C (en) 2010-08-05 2018-09-18 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
EP2600812B1 (de) * 2010-08-05 2021-09-22 ForSight Vision4, Inc. Vorrichtung zur behandlung eines auges
US8821457B2 (en) 2010-09-08 2014-09-02 Johnson & Johnson Vision Care, Inc. Punctal plug containing drug formulation
US8591484B2 (en) 2010-09-15 2013-11-26 AlphaMed, Inc. Lacrimal punctum measurement and occlusion
CA2818612C (en) 2010-11-19 2020-12-29 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US20120157938A1 (en) 2010-12-16 2012-06-21 Tokarski Jason M Punctal plug with drug core retention features
US9301874B2 (en) 2011-05-06 2016-04-05 Johnson & Johnson Vision Care, Inc. Punctal plugs for controlled release of therapeutic agents
EP4249059A3 (de) 2011-06-28 2023-11-29 ForSight Vision4, Inc. Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
EP2739252A4 (de) 2011-08-05 2015-08-12 Forsight Vision4 Inc Abgabe kleiner moleküle über eine implantierbare therapeutische vorrichtung
WO2013030679A2 (en) 2011-08-29 2013-03-07 Qlt Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
PL2755600T3 (pl) 2011-09-16 2021-09-20 Forsight Vision4, Inc. Urządzenie do wymiany płynów
US8721322B2 (en) 2011-11-30 2014-05-13 Johnson & Johnson Vision Care, Inc. Injection molding device and method
WO2013086015A1 (en) 2011-12-05 2013-06-13 Incept, Llc Medical organogel processes and compositions
US8911227B2 (en) 2012-01-11 2014-12-16 Johnson & Johnson Vision Care, Inc. Device for injection molding silicone rubber
US8808256B2 (en) * 2012-01-16 2014-08-19 Johnson & Johnson Vision Care, Inc. Eye drug delivery system
US10010448B2 (en) 2012-02-03 2018-07-03 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US20130220346A1 (en) * 2012-02-28 2013-08-29 Victor Lust Balloon punctal plug
WO2014113384A2 (en) 2013-01-15 2014-07-24 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system drug delivery device
US9968603B2 (en) 2013-03-14 2018-05-15 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
JP6385423B2 (ja) 2013-03-28 2018-09-05 フォーサイト・ビジョン フォー・インコーポレーテッド 治療物質送達用の眼移植片
US20160302965A1 (en) * 2013-12-06 2016-10-20 Forsight Vision4, Inc. Implantable therapeutic devices
JP6581194B2 (ja) 2014-07-15 2019-09-25 フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． 眼用インプラント送達装置および方法
CN107106551A (zh) 2014-08-08 2017-08-29 弗赛特影像4股份有限公司 受体酪氨酸激酶抑制剂的稳定且可溶的制剂和其制备方法
ES2756301T3 (es) 2014-08-19 2020-04-27 Univ California Implantes de administración localizada de fármacos y métodos de uso de los mismos
SG11201703726XA (en) 2014-11-10 2017-06-29 Forsight Vision4 Inc Expandable drug delivery devices and method of use
EP3240510A4 (de) 2014-12-31 2018-09-19 Microoptx Inc. Verfahren und vorrichtungen zur behandlung von glaukom
WO2016187426A1 (en) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
CA2993182A1 (en) 2015-07-22 2017-01-26 Incept, Llc Coated punctal plug
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) * 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
EP3355983A4 (de) * 2015-09-30 2019-06-26 Microoptx Inc. Vorrichtungen und verfahren zur behandlung des trockenen auges
WO2017062770A1 (en) 2015-10-08 2017-04-13 Silverberg Noah Punctal plug and bioadhesives
US10172740B2 (en) 2015-11-06 2019-01-08 David E Freilich Lacrimal stent
CN113069681B (zh) 2015-11-20 2022-12-23 弗赛特影像4股份有限公司 制造用于缓释药物递送的治疗装置的方法
WO2017091404A1 (en) 2015-11-23 2017-06-01 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
CA3019822A1 (en) 2016-04-05 2017-10-12 Forsight Vision4, Inc. Implantable ocular drug delivery devices
CN115120405A (zh) 2016-04-20 2022-09-30 多斯医学公司 生物可吸收眼部药物的递送装置
AU2017268379A1 (en) * 2016-05-20 2018-12-06 The Regents Of The University Of Colorado, A Body Corporate Lacrimal drug delivery device
WO2019103906A1 (en) 2017-11-21 2019-05-31 Forsight Vision4, Inc. Fluid exchange apparatus for expandable port delivery system and methods of use
KR20220151622A (ko) 2020-02-06 2022-11-15 오큘라 테라퓨틱스, 인코포레이티드 안질환 치료를 위한 조성물 및 방법
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
JP7378638B2 (ja) 2020-03-25 2023-11-13 オキュラ セラピューティクス，インコーポレイテッド チロシンキナーゼ阻害剤を含む眼内インプラント
AU2021358490A1 (en) 2020-10-05 2023-06-01 Max Biology Co. Ltd. Cannabinoid-containing compositions and use for treating and preventing diseases
KR20240015057A (ko) * 2021-01-15 2024-02-02 디퓨전 알엑스 인코포레이티드 치료제를 지속적이고 연속적으로 방출하는 조인트 임플란트
CN114652488A (zh) * 2022-03-22 2022-06-24 海思盖德(苏州)生物医学科技有限公司 一种眼内植入物及植入物外表复合式药物涂覆工艺

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626940A (en) 1969-05-02 1971-12-14 Alza Corp Ocular insert
US3630200A (en) 1969-06-09 1971-12-28 Alza Corp Ocular insert
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3641237A (en) 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US3993071A (en) 1971-09-09 1976-11-23 Alza Corporation Bioerodible ocular device
US3826258A (en) 1972-02-07 1974-07-30 S Abraham Gradual release medicine carrier
US3962414A (en) 1972-04-27 1976-06-08 Alza Corporation Structured bioerodible drug delivery device
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3963025A (en) 1974-09-16 1976-06-15 Alza Corporation Ocular drug delivery device
US3949750A (en) * 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US3992071A (en) 1975-04-01 1976-11-16 The United States Of America As Represented By The Secretary Of The Army Processes for activating S-1 cathode
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4834979A (en) * 1981-06-29 1989-05-30 Alza Corporation Medical bandage for administering beneficial drug
US5053030A (en) 1984-11-07 1991-10-01 Herrick Robert S Intracanalicular implant for horizontal canalicular blockade treatment of the eye
US5322691A (en) * 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4994273A (en) 1987-11-02 1991-02-19 Merck & Co., Inc. Solubility modulated drug delivery device
US4882150A (en) 1988-06-03 1989-11-21 Kaufman Herbert E Drug delivery system
US4923699A (en) 1988-06-03 1990-05-08 Kaufman Herbert E Eye treatment suspension
US4875602A (en) * 1988-06-15 1989-10-24 Triad Direct Incorporated Self-contained liquid dispensing device
CA2031960C (en) * 1989-12-19 2002-05-28 Daniel Py Ocular treatment apparatus
US5171270A (en) 1990-03-29 1992-12-15 Herrick Robert S Canalicular implant having a collapsible flared section and method
US5417682A (en) 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5283063A (en) 1992-01-31 1994-02-01 Eagle Vision Punctum plug method and apparatus
US5417651A (en) 1993-07-01 1995-05-23 Guena; Nicolas Punctum plug and monocanalicular probe for lacrimal pathology
US5423777A (en) * 1993-10-27 1995-06-13 Tajiri; Akira Punctum plug
US5725493A (en) * 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5723005A (en) 1995-06-07 1998-03-03 Herrick Family Limited Partnership Punctum plug having a collapsible flared section and method

Also Published As

Publication number Publication date
AU4205900A (en) 2000-11-02
EP1178779B1 (de) 2007-08-15
EP1891942A1 (de) 2008-02-27
EP1178779A4 (de) 2005-01-12
ES2340616T3 (es) 2010-06-07
ES2288471T3 (es) 2008-01-16
PT1178779E (pt) 2007-10-02
PT1891942E (pt) 2010-04-21
EP1178779A1 (de) 2002-02-13
EP1891942B1 (de) 2010-03-03
WO2000062760A1 (en) 2000-10-26
DK1891942T3 (da) 2010-06-07
DE60035979D1 (de) 2007-09-27
ATE369843T1 (de) 2007-09-15
DE60035979T2 (de) 2007-12-20
DK1178779T3 (da) 2007-12-10
US6196993B1 (en) 2001-03-06
ATE459343T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
DE60043959D1 (de) Ophthalmischer Einsatz und Verfahren zur stetigen Zuführung eines Arzneimittels ins Auge
US4908024A (en) Ocular self-treatment apparatus and method
EP0891753A4 (de) Künstliche hornhaut
CA2422264A1 (en) Customized vision correction method and business
US5387202A (en) Eye drop dispensing device
WO2008024982A3 (en) Ophthalmic insert
TW376317B (en) Corneal template and surgical device for refractive vision correction
CA2433849A1 (en) Glaucoma treatment device and method
BR0312816A (pt) derivação oftálmica inplantável em um olho e método de diminuir pressão ocular e de tratar glaucoma em um olho
CN206515567U (zh) 一种载药性角膜接触镜
WO2005020907A3 (en) Ocular drug delivery device
US5795342A (en) Ocular irrigation device
US20120055490A1 (en) Implantable Punctal Plug
WO2016031093A1 (ja) 眼瞼内装用具
US20040267214A1 (en) Ophthalmic device for administering fluid eye medication to the human eye
WO2002049611A3 (en) Ophthalmic lubricating solution adapted for use in lasik surgery
US5903333A (en) Contact lens for use with ophthalmic monitoring systems
US6530908B1 (en) Eye dropper positioning device
CN2502672Y (zh) 多孔灌注前房维持器
CN2169402Y (zh) 抗青光眼引流装置
JP2673537B2 (ja) 眼部処置物質自己投与装置
Kim et al. Revision of failed filtering blebs using mitomycin C
Brown et al. Effect of brimonidine on pupil diameter
CN2170751Y (zh) 多孔巩膜环
Stevens et al. Corneal modulators and their use in excimer laser phototherapeutic keratectomy

Legal Events

Date Code Title Description
8363 Opposition against the patent